Mesothelioma Report 2018 (2014-16 cohort)

 Surrey and Sussex Healthcare NHS Trust (RTP)

 South East Coast Strategic Clinical Network
 Clinical Lead: Kofi Nimako

This performance report details results for cases of pleural mesothelioma specifically for the period January 2014 - December 2016 inclusive, and compares this to the national average for the same period. Data was collected by different mechanisms in different years. Data for 2015 did not undergo detailed validation. The number of cases submitted refers to cases allocated as the "trust first seen", based on an NLCA/NCRAS algorithm. A spreadsheet containing a more detailed breakdown, and many other results is available here...

 Data completeness

Performance status (PS) describes a patient’s level of functioning in terms of their ability to care for themselves, daily activity and physical ability. It is measured using a 5-point scale which can range from 0 (good function) to 4 (poor function). Stage refers to the extent of the cancer, such as how large the tumour is and whether it has spread. The new British Thoracic Society (BTS) guidelines recommend that all cases of diagnosed MPM are staged using the new IASLC/IMIG TNM 8 clinical staging system.

Trust PS recorded Stage recorded
South East Coast 74.7% 57.8%
Royal Surrey County Hospital NHS Trust 33.3% 20.8%
Frimley Health NHS FT 74.7% 69.3%
Dartford and Gravesham NHS Trust 84.3% 39.2%
Medway NHS FT 92.4% 93.7%
Ashford and St Peter's Hospitals NHS FT 31.0% 24.1%
Surrey and Sussex Healthcare NHS Trust 85.7% 14.3%
East Kent Hospitals University NHS FT 63.0% 53.3%
Maidstone and Tunbridge Wells NHS Trust 67.7% 85.5%
East Sussex Healthcare NHS Trust 77.6% 58.2%
Brighton and Sussex University Hospitals NHS Trust 68.6% 64.7%
Western Sussex Hospitals NHS Trust 92.7% 52.4%

 Summary of Unadjusted Results

Trust Cases PCR 1 Subtype 2 LCNS 3 Anti-Cancer 4 Surgery (radical) 5 SACT in PS 0-1 6 Survival 7
South East Coast 661 89.0% 55.8% 59.8% 54.3% 5.4% 62.7% 35.7%
Royal Surrey County Hospital NHS Trust 24 83.3% 45.8% 12.5% 62.5% 8.3% 85.7% 41.7%
Frimley Health NHS FT 75 90.7% 58.7% 76.0% 64.0% 5.3% 70.2% 45.6%
Dartford and Gravesham NHS Trust 51 90.2% 80.4% 80.4% 58.8% 5.9% 47.8% 32.6%
Medway NHS FT 79 89.9% 64.6% 81.0% 54.4% 6.3% 67.6% 36.0%
Ashford and St Peter's Hospitals NHS FT 29 82.8% 31.0% 6.9% 55.2% 0.0% 71.4% 46.2%
Surrey and Sussex Healthcare NHS Trust 49 95.9% 73.5% 85.7% 46.9% 2.0% 42.4% 29.5%
East Kent Hospitals University NHS FT 92 90.2% 60.9% 28.3% 58.7% 4.3% 75.6% 36.0%
Maidstone and Tunbridge Wells NHS Trust 62 85.5% 59.7% 64.5% 50.0% 14.5% 54.8% 40.0%
East Sussex Healthcare NHS Trust 67 88.1% 41.8% 43.3% 41.8% 3.0% 62.5% 29.2%
Brighton and Sussex University Hospitals NHS Trust 51 88.2% 56.9% 51.0% 45.1% 3.9% 61.1% 24.5%
Western Sussex Hospitals NHS Trust 82 87.8% 32.9% 79.3% 58.5% 4.9% 62.1% 35.9%
England 6642 88.2% 63.3% 52.1% 51.4% 4.5% 58.8% 38.0%

1 Proportion of all patients with pathological confirmation of mesothelioma :: 2 Proportion of all patients whose mesothelioma is subtyped :: 3 Proportion of all patients assessed by a specialist nurse :: 4 Proportion of all patients who have anti-cancer treatment (surgery, radiotherapy, systemic treatment) :: 5 Proportion of patients who undergo radical surgery :: 6 Proportion of patients with with PS 0-1 who have systemic anti-cancer treatment :: 7 Proportion of patients alive at 1 year after diagnosis